GENFIT S A has a total of 23 patent applications. Its first patent ever was published in 2000. It filed its patents most often in France, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BIOXELL SPA, CARNOT LLC and SHAN DONG LUYE PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 21 | |
#2 | United States | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Caumont Bertrand Karine | 9 |
#2 | Najib Jamila | 8 |
#3 | Darteil Raphael | 4 |
#4 | Staels Bart | 4 |
#5 | Majd Zouher | 3 |
#6 | Delhomel Jean Francois | 2 |
#7 | Martin Genevieve | 2 |
#8 | Barradeau Sebastien | 2 |
#9 | Sayah-Jeanne Sakina | 1 |
#10 | Sayha Jeanne Sakina | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006077012A2 | USE OF LXR LIGANDS FOR THE MODULATION OF DENDRITIC CELLS (DCs) | |
FR2893942A1 | In vitro screening of nuclear receptor modulators comprises contacting test compound with polypeptide nuclear receptor-ligand binding domain and polypeptide cofactor-nuclear receptor interaction domain and revealing their interaction level | |
FR2847266A1 | Selection of compounds that modulate efflux of cholesterol, useful for treating e.g. atherosclerosis, from their ability to modulate activity of adipophilin | |
FR2843395A1 | New synthetic peptide from apolipoprotein AIV related protein, useful for raising antibodies, used for diagnosis and treatment of disorders of lipid metabolism | |
FR2829581A1 | New synthetic peptide from apolipoprotein AIV related protein, useful for raising antibodies, used for diagnosis and treatment of disorders of lipid metabolism |